Description
Deboc-cabazitaxel or De-boc-cabazitaxel is an impurity in the synthesis of cabazitaxel. The latter is an anti-cancer agent derived from taxol. Cabazitaxel is used in the treatment of castration-resistant prostate cancer.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Deboc-cabazitaxel or De-boc-cabazitaxel is an impurity in the synthesis of cabazitaxel. The latter is an anti-cancer agent derived from taxol. Cabazitaxel is used in the treatment of castration-resistant prostate cancer.
| Cas No. | 1638286-64-2 |
|---|---|
| Purity | ≥95% |
| Formula | C40H49NO12 |
| Formula Wt. | 735.83 |
| Synonym | De-boc-Cabazitaxel |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Mast cell stabilizer; TRPV2 antagonist, PDGFR i...
PDE3/5 inhibitor, LTD4 antagonist.
Spirodihydrobenzofuranlactam
Protease inhibitor.
Triterpene saponin found in Panax; Kv7.1 K+ cha...
EGFR (WT, T790M) inhibitor.
Cyclic peptide; calcineurin inhibitor.
Endogenous peptide, cleavage product of angiote...
Dual RAF/EGFR inhibitor.
AT1 inhibitor.
Hydrophobic β-lactam; penicillin binding prote...
Voltage-gated Na+ channel blocker, mAChR antago...
NSAID; COX-1/2 inhibitor.
Imidazoline derivative; α1-adrenergic agonist,...
mGluR5 positive modulator.
Pyrimidine analog; inhibits thymidylate synthas...
Tetracycline; FIASMA, histamine H1, 5-HT2, mACh...
Endogenous peptide hormone, involved in feeding...
PDE and adenosine deaminase inhibitor.
Selective HDAC4 and HDAC5 inhibitor.